Ironwood Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Ironwood Pharmaceuticals, Inc.‘s stocks are currently a part of 233 hedge funds’ portfolios, which represents 91.7% of the total amount of its stocks outstanding. This makes up a total of 173.80M shares of Ironwood Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 6.27% or 10.26M shares more. As for the holding position changes, 30.9% (72) of current hedge fund investors increased the number of shares held, 33.48% (78) of current holders sold a part of the shares held, and 12.88% (30) closed the holdings completely. 56 hedge funds are new holders of Ironwood Pharmaceuticals, Inc. stock in Q2 2022, it is 24.03% of total holders.
Hedge funds holding Ironwood Pharmaceuticals (Q3 2017 – Q2 2022)
| Q3 2017 | 150 |
|---|---|
| Q4 2017 | 159 |
| Q1 2018 | 150 |
| Q2 2018 | 149 |
| Q3 2018 | 152 |
| Q4 2018 | 143 |
| Q1 2019 | 156 |
| Q2 2019 | 152 |
| Q3 2019 | 162 |
| Q4 2019 | 194 |
| Q1 2020 | 191 |
| Q2 2020 | 198 |
| Q3 2020 | 185 |
| Q4 2020 | 196 |
| Q1 2021 | 205 |
| Q2 2021 | 207 |
| Q3 2021 | 222 |
| Q4 2021 | 210 |
| Q1 2022 | 212 |
| Q2 2022 | 233 |
Hedge funds changes in Ironwood Pharmaceuticals positions (Q3 2017 – Q2 2022)
| Q3 2017 | 13 | 63 | 39 | 27 | 8 |
|---|---|---|---|---|---|
| Q4 2017 | 27 | 51 | 49 | 18 | 14 |
| Q1 2018 | 22 | 38 | 56 | 25 | 9 |
| Q2 2018 | 25 | 50 | 45 | 27 | 2 |
| Q3 2018 | 21 | 45 | 53 | 17 | 16 |
| Q4 2018 | 28 | 51 | 41 | 36 | -13 |
| Q1 2019 | 34 | 55 | 44 | 22 | 1 |
| Q2 2019 | 30 | 61 | 29 | 31 | 1 |
| Q3 2019 | 32 | 63 | 34 | 21 | 12 |
| Q4 2019 | 43 | 54 | 68 | 11 | 18 |
| Q1 2020 | 29 | 63 | 69 | 30 | 0 |
| Q2 2020 | 29 | 87 | 52 | 21 | 9 |
| Q3 2020 | 23 | 66 | 65 | 35 | -4 |
| Q4 2020 | 38 | 67 | 61 | 27 | 3 |
| Q1 2021 | 38 | 74 | 65 | 28 | 0 |
| Q2 2021 | 34 | 75 | 66 | 30 | 2 |
| Q3 2021 | 35 | 84 | 69 | 18 | 16 |
| Q4 2021 | 29 | 70 | 77 | 41 | -7 |
| Q1 2022 | 36 | 62 | 77 | 32 | 5 |
| Q2 2022 | 56 | 72 | 78 | 30 | -3 |
Hedge funds changes in Ironwood Pharmaceuticals stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 12,862,000 | 10,424,000 |
|---|---|---|
| Q4 2017 | 17,831,000 | 8,923,000 |
| Q1 2018 | 16,985,000 | 6,947,000 |
| Q2 2018 | 27,318,000 | 12,794,000 |
| Q3 2018 | 21,842,000 | 10,679,000 |
| Q4 2018 | 18,509,000 | 6,845,000 |
| Q1 2019 | 24,032,000 | 8,252,000 |
| Q2 2019 | 8,760,000 | 6,198,000 |
| Q3 2019 | 7,831,000 | 5,962,000 |
| Q4 2019 | 11,315,000 | 8,925,000 |
| Q1 2020 | 6,982,000 | 1,024,000 |
| Q2 2020 | 13,840,000 | 7,149,000 |
| Q3 2020 | 12,203,000 | 5,813,000 |
| Q4 2020 | 60,000,015,890,000 | 6,560,000 |
| Q1 2021 | 6,416,000 | 5,693,000 |
| Q2 2021 | 14,619,000 | 2,998,000 |
| Q3 2021 | 13,144,000 | 2,869,000 |
| Q4 2021 | 8,351,000 | 1,339,000 |
| Q1 2022 | 238,000 | 734,000 |
| Q2 2022 | 876,000 | 231,000 |